Unique ID issued by UMIN | UMIN000041682 |
---|---|
Receipt number | R000047330 |
Scientific Title | Residues of insulin secretion differ at the different site of pancreatic cancer in spite of diabetes history |
Date of disclosure of the study information | 2021/03/31 |
Last modified on | 2020/09/04 13:52:27 |
Residues of insulin secretion differ at the different site of pancreatic cancer in spite of diabetes history
Residues of insulin secretion differ at the different site of pancreatic cancer in spite of diabetes history
Residues of insulin secretion differ at the different site of pancreatic cancer in spite of diabetes history
Residues of insulin secretion differ at the different site of pancreatic cancer in spite of diabetes history
Japan |
diabetes, pancreatic cancer
Gastroenterology | Hepato-biliary-pancreatic medicine | Endocrinology and Metabolism |
Hepato-biliary-pancreatic surgery |
Malignancy
NO
A retrospective study of diabetic pancreatic cancer patients
Others
we examined the clinical background of pancreatic cancer patients with diabetes mellitus retrospectively due to focusing whether diabetes becomes as an ordinal factor for early detection or progression of pancreatic cancer
Confirmatory
Others
Not applicable
the levels of serum or urinary C-peptide immunoreactivity (CPR)
Age, sex, height, BMI, family history of diabetes mellitus, history of smoking alcohol, family history of malignant disease, duration of diabetes, HbA1c,weight loss and period, treatment (oral hypoglycemic agent or insulin treatment or both), tumor marker (CA19-9), tumor diameter, pancreatic cancer development site and cancer treatment
Observational
55 | years-old | <= |
80 | years-old | >= |
Male and Female
Diabetic patients with pancreatic cancer
Patients who refused or could not be followed for pancreatic cancer
52
1st name | Hirotaka |
Middle name | |
Last name | Shichijo |
Kyorin University School of Medicine
Department of Diabetes, Endocrinology and Metabolism
1818611
Tokyo, Japan
0422475511
hirotaka.shichijo0210@gmail.com
1st name | Hirotaka |
Middle name | |
Last name | Shichijo |
Kyorin University School of Medicine
Department of Diabetes, Endocrinology and Metabolism
1818611
Tokyo, Japan
0422475511
hirotaka.shichijo0210@gmail.com
Department of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine
Department of Diabetes, Endocrinology and Metabolism, Kyorin University School of Medicine
Self funding
Japan
Kyorin University School of Medicine
Tokyo, Japan
0422475511
hirotaka.shichijo0210@gmail.com
NO
2021 | Year | 03 | Month | 31 | Day |
Unpublished
36
No longer recruiting
2020 | Year | 05 | Month | 12 | Day |
2020 | Year | 05 | Month | 12 | Day |
2020 | Year | 05 | Month | 12 | Day |
2022 | Year | 12 | Month | 31 | Day |
The relationship between diabetes and cancer risk has been previously shown, and various studies have shown the relationship between diabetes and cancer risk.
Pancreatic cancer is one of the cancers whose risk is increased by diabetes, but it is difficult to detect it early, and it is often advanced at the time of diagnosis, and it is known as a cancer with a poor prognosis. Conceivable. Even in outpatient clinics, patients with type 2 diabetes are diagnosed with pancreatic cancer due to poor glycemic control, and new cases of new onset.
In diabetes, we sometimes experience cases in which it is revealed that the disease is secondary diabetes due to pancreatic cancer, and it is very important to detect pancreatic cancer as early as possible. That is, the deterioration of blood glucose level and the onset of diabetes in diabetic patients are important as early detection markers for pancreatic cancer, but clinical characteristics due to differences in the background depending on the site of pancreatic cancer and the presence or absence of presymptomatic diabetes have not been reported. ..
This time, in order to clarify whether glucose metabolism abnormality is useful as an early detection marker for pancreatic cancer, clinical characteristics of diabetic patients with pancreatic cancer (site, presence or absence of presymptomatic diabetes, insulin secretory capacity, weight change, etc.) Retrospectively investigate.
2020 | Year | 09 | Month | 04 | Day |
2020 | Year | 09 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047330
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |